Essential oils for COVID-19 management: A systematic review of randomized controlled trials

Authors

  • Teuku F. Duta Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
  • Diva R. Rizki Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
  • Agnia Purnama Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia
  • Marius Rademaker Clinical Trial New Zealand, Waikato Hospital Campus, Hamilton, New Zealand
  • Uwe Wollina Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany
  • Yogesh Acharya Western Vascular Institute, Galway University Hospital, Galway, Ireland
  • Ziad Abdeen Department of Community Health, Faculty of Medicine, Al-Quds University, East Jerusalem, Palestine
  • Sandro G. V. Rosa Division of Pharmacy, National Institute of Industrial Property, Rio de Janeiro, Brazil
  • Henning B. Nielsen Department of Anesthesia and Intensive Care, Zealand University Hospital Roskilde, Roskilde, Denmark; Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark
  • Kannan Subbaram School of Medicine, The Maldives National University, Maldives

DOI:

https://doi.org/10.52225/narrax.v1i2.84

Keywords:

Volatile compound, aromatherapy, COVID-19, SARS-CoV-2 infection, respiratory tract infection

Abstract

Essential oils can be a beneficial adjuvant therapy in managing coronavirus disease 2019 (COVID-19). This systematic review aims to evaluate the efficacy of essential oils in ameliorative COVID-19-related symptoms. Published studies reporting the efficacy of essential oils as adjuvant therapy for COVID-19 were screened on Scillit, Scopus, SciFinder, and PubMed (December 7th, 2022). Inclusion criteria include the randomized controlled trials (RCTs) participated by those diagnosed with COVID-19 and treated with essential oils as adjuvant therapy. Quality assessment was carried out using Cochrane ‘risk-of-bias’ 2.0 tool. A total of 2112 records were retrieved from the initial screening, which was reduced to four publications (n=344 individuals). The foregoing studies reported that essential oils could improve the recovery rate, alleviate post-COVID-19 fatigue, and prevent disease progression. Regarding their potential antiviral activity, better designed studies are needed. In conclusion, essential oils as adjuvant therapy are beneficial in ameliorating mild COVID-19 symptoms.

Downloads

Published

2023-08-31

Issue

Vol. 1 No. 2 (2023): August 2023

Section

Short Communication

License

Copyright (c) 2023 Teuku Fais Duta, Diva R. Rizki, Agnia Purnama , Marius Rademaker, Uwe Wollina, Yogesh Acharya, Ziad Abdeen, Sandro G. Viveiros Rosa, Henning B. Nielsen, Kannan Subbaram

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.